A faecal microbiota signature with high specificity for pancreatic cancer. PCC8729007
2 studies · 320 curated samples · 224 distinct subject identifiers · 2 shared papers. Grouping rule: shared paper, same submitting centre.
Age categories
| adult | 198 |
| elderly | 122 |
Countries
| ES | 244 |
| DE | 76 |
Health conditions
| other_cancer Other cancer (incl. immunotherapy cohorts) | 70 |
| healthy_control Healthy / control | 64 |
| obesity Obesity / overweight | 8 |
| other_disease Other disease / condition | 8 |
| type2_diabetes Type 2 diabetes / prediabetes | 2 |
| allergy_or_atopy Allergy / atopy / asthma | 1 |
Studies
| study | title | samples | source |
|---|---|---|---|
| PRJEB38625 | The oral and fecal microbiome in chronic pancreatitis and pancreatic cancer. | 244 | gut_all_v1 |
| PRJEB42013 | Non-invasive, robust and specific fecal microbiota-based screening for the early detection of PDAC. | 76 | gut_all_v1 |
Shared papers
- A faecal microbiota signature with high specificity for pancreatic cancer. — PMID 35260444 · PMC9185815 · doi · studies: PRJEB38625, PRJEB42013
- Highly accurate diagnosis of pancreatic cancer by integrative modeling using gut microbiome and exposome data. — PMID 38450156 · PMC10915599 · doi · studies: PRJEB38625, PRJEB42013